Tardive Dyskinesia (TD) - Managing a Difficult Side Effect (Ep. 119)
More than 14 million Americans have a serious mental illness, such as bipolar disorder, major depressive disorder or schizophrenia – conditions that can be treated with antipsychotic medicines. Use of these medicines has increased 22% in recent years, particularly within the last 10 years, in turn increasing the risk of a debilitating chronic movement condition called tardive dyskinesia (TD), which can cause uncontrollable and repetitive movements that make eating, drinking and walking difficult.
While TD can be treated, integrating new medicines into existing treatment plans can be difficult, and people living with schizophrenia may worry that treating TD could cause regression in their mental illness.
A one-pill, once-daily treatment option exists that can be integrated into existing mental health treatment plans, helping people manage their mental health and TD in tandem.
